1Parkin D M,Muir C S.Cancer Incidence in Five Continents.Comparability and quality of data.IARC Sci Publ,1992,120:45-173. 被引量:1
2Thissen M R,Neumann M H,Schouten L J.A systemic review of treatment modalities for primary basal cell carcinomas.Arch Dermatol,1999,135:1177-1183. 被引量:1
3Albert M R,Weinstock M A.Keratinocyte carcinoma.CA Cancer J Clin,2003,53:292-302. 被引量:1
4de Vries E,Louwman M,Bastiaens M,et al.Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973.J Invest Dermatol,2004,123:634-638. 被引量:1
5Cheng S Y,Luk N M,Chong L Y.Special features of non-melanoma skin cancer in Hong Kong Chinese patients:10-year retrospective study.Hong Kong Med J,2001,7:22-28. 被引量:1
6Rawashdeh M A,Matalka I.Basal cell carcinoma of the maxillofacial region:site distribution and incidence rates in Arab/Jordanians,1991 to 2000.J Oral Maxillofac Surg,2004,62:145-149. 被引量:1
7Tan S H,Tham S N,Goh C L.Skin cancers at Tertiary Referral Skin Hospital in Singapore.Int J Dermatol,1995,34:770-776. 被引量:1
8Miller S J.Etiology and pathogenesis of basal cell carcinoma.Clin Dermatol,1995,13:527-536. 被引量:1
9Snow S N,Sahl W,Lo J S,et al.Metastatic basal cell carcinoma:Report of five cases.Cancer,1994,73:328-335. 被引量:1
10Lo J S,Snow S N,Reizner G T,et al.Metastatic basal cell carcinoma:report of twelve cases with a review of the literature.J Am Acad Dermatol,1991,24(5Pt 1):715-719. 被引量:1
7Albert MR,Weinstock MA.Keratinocyte carcinoma[J].CA Cancer J Clin,2003,53:292-302. 被引量:1
8Miller DL,Weinstock MA.Nonmelanoma skin cancer in the United States:incidence[J].J Am Acad Dermatol,1994,30:774-778. 被引量:1
9Slaper H,Velders GJM,Daniel JS,et al.Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements[J].Nature,1996,384:256-258. 被引量:1
10Cheng SY,Luk NM,Chong LY.Special features of non-melanoma skin cancer in Hong Kong Chinese patients:10-year retrospective study[J].Hong Kong Med J,2001,7:22-28. 被引量:1